title: [Ventricular tachycardia : Treatment and prognostic significance].
abstract: Dilative cardiomyopathy (DCM) has an incidence of 5-8/100,000 inhabitants, and hypertrophic cardiomyopathy an incidence of 1/500 inhabitants. Depending on specific risk factors both conditions have an increased risk for sudden cardiac death (SCD): in DCM reduced left ventricular ejection fraction and reduced physical capacity; and in HCM SCD in family members, left ventricular septum  > 30 mm, unclear syncope, non-sustained ventricular tachycardia (VT) on holter-ECG and inadequate blood pressure response on ergometer. Especially patients with intermediary risk factors are insufficiently classified, and the lifesaving implantation of a cardioverter-defibrillator (ICD) often leads to a significant number of device-related complications. In this area additional methods like late enhancement imaging with cardio MRI, identification of genetic variation and ECG characteristics could help improve risk stratification in these patients.
authors.affiliation: Medizinische Klinik und Poliklinik I, Klinikum Großhadern, Ludwig-Maximilians-Universität München, München, Deutschland, Stephanie.Fichtner@med.uni-muenchen.de.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Fichtner
authors.forename: Stefan
authors.initials: S
authors.lastname: Kääb
mesh_terms: D009202:Cardiomyopathies / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D017147:Defibrillators, Implantable; D004562:Electrocardiography / Q000379:methods*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D017180:Tachycardia, Ventricular / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*